InsidersTradesSigma
Total declarations
Companies
▲ Purchases (12 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
12
Disclosed sells
0
T+90 hit rate
18%
T+90 mean return
-5.5%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Whitman Burke W, Director. Insider active across 2 companies, notably Amicus Therapeutics, INC.. In total, 23 filings have been logged. Breakdown: 12 buys · 0 sell. Total volume traded: €164k. History available since 3 May 2021. The latest transaction was filed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Whitman Burke W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
118,598 shares@ US$14.500.037% mcap89.9% of flowCommon StockSEC:0001193125-26-182279:0
4,388 shares@ US$37.6019.0% of flowCommon StockSEC:0001415889-25-016461:0
20,414 shares0Common StockSEC:0000950170-25-083192:0
4,605 shares@ US$32.5716.9% of flowCommon StockSEC:0001415889-24-016349:0
11,847 shares0Common StockSEC:0000950170-24-071010:0
8,584 shares0Common StockSEC:0001209191-23-036415:0
4,995 shares@ US$30.0317.2% of flowCommon StockSEC:0001415889-23-009383:0
12,671 shares0Common StockSEC:0001209191-22-035862:0
5,131 shares@ US$29.230.0011% mcap26.0% of flowCommon StockSEC:0001415889-22-006173:0
1,500 shares@ US$10.490.0003% mcap8.3% of flowCommon StockSEC:0001209191-21-062795:0
Canonical exit: 30 Jan 2022 (T+90)
1,500 shares@ US$9.5640.8% of flowCommon StockSEC:0001209191-21-059153:0
Canonical exit: 30 Dec 2021 (T+90)
1,500 shares@ US$11.410.9% of flowCommon StockSEC:0001209191-21-055057:0
Canonical exit: 30 Nov 2021 (T+90)
500 shares@ US$33.651.9% of flowCommon StockSEC:0001127602-21-024647:0
Canonical exit: 30 Nov 2021 (T+90)
1,500 shares@ US$9.280.8% of flowCommon StockSEC:0001209191-21-049703:0
Canonical exit: 31 Oct 2021 (T+90)
500 shares@ US$36.502.0% of flowCommon StockSEC:0001127602-21-022727:0
Canonical exit: 31 Oct 2021 (T+90)
1,500 shares@ US$9.600.8% of flowCommon StockSEC:0001209191-21-046712:0
Canonical exit: 29 Sept 2021 (T+90)
500 shares@ US$36.302.0% of flowCommon StockSEC:0001127602-21-020924:0
Canonical exit: 29 Sept 2021 (T+90)
10,115 shares0Common StockSEC:0001209191-21-040381:0
3,949 shares@ US$37.9816.2% of flowCommon StockSEC:0001127602-21-019505:0
1,500 shares@ US$9.24080.7% of flowCommon StockSEC:0001209191-21-037394:0
Canonical exit: 30 Aug 2021 (T+90)
500 shares@ US$36.962.0% of flowCommon StockSEC:0001127602-21-018398:0
Canonical exit: 30 Aug 2021 (T+90)
1,500 shares@ US$10.210.8% of flowCommon StockSEC:0001209191-21-030440:0
Canonical exit: 1 Aug 2021 (T+90)
500 shares@ US$38.162.1% of flowCommon StockSEC:0001127602-21-015107:0
Canonical exit: 1 Aug 2021 (T+90)
23 of 23 declarations
About Whitman Burke W
WHITMAN BURKE W is a Director at Amicus Therapeutics, INC. and Omega Healthcare Investors INC. He has 23 filings in total, and across the recent sample of 23 filings the activity runs from 2021-05-04 to 2026-04-27, with EUR 164229 of buys and EUR 1466862 of sells.
